baber/WOPTO huggingface dataset:
Patent AT-E182458-T1 (AT)
Inventor: LABELLE HUBERT
IPC: A61F5/02
Filed: 1994-12-22
Granted: 1999-08-15
Abstract: A series of ortheses for the treatment of scoliotic deformities are each adapted for obliquely applying dynamic derotational forces on the thorax and lumbar spine of the user in opposite directions combined with a kyphosing action on the thorax and a lordosing action on the lumbar spine. The orthoses are designed in order that the correcting forces can be applied on the user's trunk with various degree of mechanical force while allowing for complete or partial mobility of the trunk. The various orthoses can treat small, moderate and substantially severe deformities which are supple or rigid. A supple orthosis for small and supple curves comprises a thoracic garment encircling the upper thorax, short pants to provide a grip around the pelvic girdle and the upper thighs, and upper and lower semi-elastic straps having supple thoracic and lumbar pads, respectively, attached respectively to the garment and the pants. The straps which connect the pads encircle obliquely the trunk for exerting the derotational forces and the kyphosing and lordosing actions. For moderate and supple curves, semi-rigid thoracic, lumbar and pelvic pads are incorporated in the orthosis. For rigid curves, the orthosis comprises a supple plastic shell encircling the pelvic girdle, a vertical member extending posteriorly and upward from the shell and comprising thoracic and lumbar pads. Semi-elastic strap means extend anteriorly between the pads while encircling obliquely the trunk. The vertical member can be integral with the shell or, for more rigidity, can consist of metallic member attached to the shell.
Patent AT-E237690-T1 (AT)
Inventor: WIEDERRECHT GREGORY J
IPC: G01N33/53
Filed: 1995-02-10
Granted: 2003-05-15
Abstract: A new homogeneous cytosolic binding protein (FKBP12.6), having a specific binding activity of about 4.8 mg FK-506 per mg protein and a molecular weight of about 10-12 kilodaltons, reversibly binds the immunosuppressant FK-506, but not cyclosporine A (CSA). The protein is unstable to heating at 56 DEG  C. for 30 minutes losing its FK-506 binding affinity. The FKBP12.6 protein is isolated from the cytosol of mammalian tissues, preferably bovine or human brain tissue, and can be used in diagnostic and purification procedures involving FK-506-type macrolide immunosuppressants. The FKBP12.6 protein also has peptidyl-proline isomerase enzymatic activity, catalyzing the cis-trans isomerization of proline-containing peptide bonds. In addition, FKBP12.6 binds to and inhibits the phosphatase calcineurin in the presence of FK-506.
Patent AT-E171573-T1 (AT)
Inventor: GLAS VITUS
IPC: H02J13/00
Filed: 1995-07-27
Granted: 1998-10-15
Abstract: A data bus (DB) includes a series of substations (U1-U12) which are connected to operational devices (NB1...) and connected at network points to earthed cable screens (KE) of neighbouring sections of power transmission lines (NK1...). They feed data into, or tap data from, the earth current circuits (ES1, ES2). A central control unit (ZSE) feeds in an interrogation message (GAB, KAT, TAB) addressed to the final substation (U12) in the series. This message is retransmitted by each successive substation down to the final substation, which on receiving the interrogation message feeds in a response message (KAT; AT12) addressed to the central control unit. Once it has received at least one response message, but only if there have been changes in status in connected operational devices, each successive substation also feeds in its own response message containing the changes in status.
Patent AT-E198990-T1 (AT)
Inventor: SINN HANSJOERG
IPC: A61K45/00
Filed: 1995-09-26
Granted: 2001-02-15
Abstract: PCT No. PCT/DE95/01337 Sec. 371 Date Sep. 23, 1997 Sec. 102(e) Date Sep. 23, 1997 PCT Filed Sep. 26, 1995 PCT Pub. No. WO96/10422 PCT Pub. Date Apr. 11, 1996The present invention relates pharmaceutical compositions comprising a conjugate of an active substance, a linker and a carrier for the treatment and/or diagnosis of inflammatory diseases. The present invention further relates to methods using such pharmaceutical compositions for treating and diagnosing inflammatory diseases including, but not limited to, infectious diseases, autoimmune diseases, skin diseases, and inflammatory neovascularization.
Patent AT-E169165-T1 (AT)
Inventor: SPITALER WOLFGANG
IPC: H02M1/12
Filed: 1995-12-08
Granted: 1998-08-15
Abstract: A power rectifier circuit for power supply units, especially for switched mode power supply units, with a full-wave rectifier (D1...D4) on the supply voltage and, connected downstream thereof, a charging capacitor (CL), wherein the load resistor is at the output of the full-wave rectifier (D1...D4) and the charging capacitor (CL) is connected to the load resistor (SNT) through a diode (DA), with a controlled switch (ST) connected in parallel thereto, this switch being controlled by a control circuit (AT) so that it periodically closes at double the supply frequency in a time range at the zero crossings of the rectified half-waves.
Patent AT-E193872-T1 (AT)
Inventor: WHITE JEFFREY A
IPC: C02F1/20
Filed: 1996-04-15
Granted: 2000-06-15
Abstract: A method of processing waste water comprises atomizing waste water under selected atmospheric conditions to achieve substantially complete phase change of the water. The atomization is conducted by spraying waste water from a nozzle mounted on a tower adjacent a catchment area for collecting ice crystals produced by the phase change of the atomized waste water into ice crystals, under atmospheric conditions favourable to freezing of atomized water droplets into ice. <IMAGE>
Patent AT-E206680-T1 (AT)
Inventor: ELWERT FRANCOIS
IPC: B65D5/30
Filed: 1996-11-29
Granted: 2001-10-15
Abstract: The package, made from a non-polluting sheet material such as card, consists of a base (1) with a recess (3) for the packaged article (B). The recess is made from flaps (33, 77; 35, 79) cut out and folded downwards from the upper surface (9) of the base, the edges (29, 87) of which are also folded down to give it depth and fastened by tongues (91) and slits (89). A cover (93) of similar material has a window (105) corresponding to the position of the recess so that the article contained can be seen without opening the package.
Patent AT-E206911-T1 (AT)
Inventor: ASMUSSEN BODO
IPC: A61K47/30
Filed: 1996-01-10
Granted: 2001-11-15
Abstract: In a solid medicament form for the peroral application of active agents containing a uniform distribution of active agent in a polymer material, the polymer material is in the form of flat fragments.
Patent AT-E175159-T1 (AT)
Inventor: GO GIOK DJIEN DR-ING
IPC: B60N2/04
Filed: 1996-07-25
Granted: 1999-01-15
Abstract: In view of the problems that lateral air bags have shown in practice, such as protection of just one part of the body, acceleration values twice those of front air bags, burn injuries, more frequent spurious release due to very short inflation time, high production costs and costly recalls for functional checks, the invention of the lateral air bag replacement systems (B-B7) is designed to increase reliability and survivability while reducing costs by using the already mass-produced energy-absorbing parts of spring-action systems that have been tried and tested in the automobile industry for many years, such as spring elements, resilient bodies and shock absorbers, by lengthening the release time, by providing an inflatable safety air bag (80) to stop the upper body after recoil and by using the lateral impact energy to deform the parts and to displace the passenger from the danger zone to the middle of the vehicle by means of a slewing mechanism (1.70a, 1.72a, 1.71a, 1.72) equipped with a leaf spring (11c3), when the lateral impact energy is transmitted into the base (6) of the vehicle, thus reducing the b and <u>Ö</u> acceleration-dependent forces (FB and FD) to which the passenger is subjected.
Patent AT-E399203-T1 (AT)
Inventor: KEYT BRUCE
IPC: C12N15/09
Filed: 1996-08-23
Granted: 2008-07-15
Abstract: The present invention involves the preparation of vascular endothelial growth factor (VEGF) variants which provide materials that are selective in respect of binding characteristics to the kinase domain region and the FMS-like tyrosine-kinase region, respectively KDR and FLT-1. The respective KDR and FLT-1 receptors are bound by corresponding domains within the VEGF compound domains. The variants hereof define those two binding regions and modify them so as to introduce changes that interrupt the binding to the respective domain. In this fashion the final biological characteristics of the VEGF molecule are selectively modified.
Patent AT-E201075-T1 (AT)
Inventor: ARDERN FERGUS JONATHAN
IPC: E01C9/08
Filed: 1996-11-14
Granted: 2001-05-15
Abstract: PCT No. PCT/GB96/02801 Sec. 371 Date Sep. 25, 1998 Sec. 102(e) Date Sep. 25, 1998 PCT Filed Nov. 14, 1996 PCT Pub. No. WO97/18353 PCT Pub. Date May 22, 1997In an articulated sequence or array of ground-reinforcement panels, each panel has parallel rectilinear edges, one of them provided with a number of male interlock members projecting therefrom in the plane of the panel and the other provided with a corresponding number of female interlock members recessed therein, so constructed and arranged that the male members can be forcibly but detachably interengaged with the female members in a next-adjacent panel in a direction vertical to the plane of the panels but cannot be disengaged therefrom in the plane of the panels, while, when interengaged, the respective male and female members and the adjacent panels associated therewith are capable of limited rotation with respect to each other.
Patent AT-E200848-T1 (AT)
Inventor: WAGNER PETER
IPC: A21D8/04
Filed: 1996-12-20
Granted: 2001-05-15
Abstract: A dough- or bread-improving composition containing a pyranose oxidase as well as the use of the composition in the preparation of dough and baked products.
Patent AT-E242883-T1 (AT)
Inventor: MORRISSEY JAMES H
IPC: C12N15/09
Filed: 1996-11-22
Granted: 2003-06-15
Abstract: An assay has been developed to detect the presence of blood clotting factors, including factors VIII and IX, utilizing mutated tissue factor. Mutated forms of wild type tissue factor as well as various forms of truncated tissue factor can be used. Preferably, substitutions of glutamine, alanine, glutamic acid, or combinations thereof are made at amino acid positions 165, 166 or 165 and 166. Various tissue factor mutants exhibit different extents of activity in supporting FVIII and FIX activation: Q<165>Q<166> > A<165>A<166> > E<165>E<166>.
Patent AT-E206580-T1 (AT)
Inventor: MIKAWA ISAO
IPC: A01C11/00
Filed: 1997-03-14
Granted: 2001-10-15
Abstract: A seedling transportation apparatus for a transplantation machine transports a seedling tray not in an upright condition or in a curved or bent condition but in a horizontal condition. The seedling transportation apparatus includes a seedling taking out apparatus (B) for taking out a seedling (P) upwardly from a seedling tray (T) having seedling accommodating cells (Ta) in which seedlings (P) are accommodated, a tray transportation apparatus (C) having a horizontal transport path for transporting the seedling tray (T) toward said seedling taking out apparatus (B), a seedling carrying out conveyor (D) disposed at a location higher than said horizontal transport path of said tray transportation apparatus (C), and a transferring apparatus (E) for transferring the seedling (P) taken out by said seedling taking out apparatus (B) onto said seedling carrying out conveyor (D). <IMAGE>
Patent AT-E198306-T1 (AT)
Inventor: PETZOLD WERNER
IPC: A61J1/03
Filed: 1997-09-10
Granted: 2001-01-15
Abstract: The tablet dispenser comprises a prismatic housing (20) whose base surface (22) has a rectangular base opening (21) set on its side surface. Its roof surface (30) has its entire cross section open, whilst above its side surface (34,35) is a recess (29). There is a prismatic supply chamber (12) with a vertically oriented tablet dispensing shaft (13) provided on the base of the chamber. The shaft is guide through base opening of the housing and a spring (14) that is supported against the base surface of the housing, as well as a mount (23) arranged to an elevation limit.
Patent AT-E215326-T1 (AT)
Inventor: AUMUELLER HANNS
IPC: A46B15/00
Filed: 1997-11-11
Granted: 2002-04-15
Abstract: The disposable tooth hygiene unit (1) is made of biodegradable plastic and consists of a cylindrical case (2), containing toothpaste, with a threaded area (26,27) on top, a longitudinal indent (25) at one of the sides for the accommodation of the toothbrush handle for transport and a lid (23) with a seal in order to close the toothpaste container (2). For use the toothbrush (3,4) can be screwed to the case (2) with an inner thread.
Patent AT-E190233-T1 (AT)
Inventor: LATTIN GARY A
IPC: A61N1/30
Filed: 1993-12-30
Granted: 2000-03-15
Abstract: A device for the electrically assisted delivery of a therapeutic agent is described. The device (500) comprises one or more rigid zones. The skin side of the rigid zone has a radius of curvature (520) which approximates that of the body site to which the device (500) is to be attached. <IMAGE>
Patent AT-E251748-T1 (AT)
Inventor: MAGONI PASCAL
IPC: G01N21/90
Filed: 1997-03-18
Granted: 2003-10-15
Abstract: The container (1) is typically a glass bottle which is orientated so that any glass debris is concentrated in as small an area as possible. A source of quasi-monochromatic light (17) such as a laser directs a beam through a polarising filter (19) to the area where any debris (15') may be expected. Light from the container (1) is received on a translucent screen (25). It then passes through polarising and interference filters (19,23) to a photoelectric detector such as a video camera (21). The output from the video camera is passed to an image processor (26) via an analogue to digital convertor and analysed according to variations in luminous intensity.
Patent AT-E209225-T1 (AT)
Inventor: RINK HEINZ-PETER
IPC: C08G18/62
Filed: 1997-01-15
Granted: 2001-12-15
Abstract: PCT No. PCT/EP97/00149 Sec. 371 Date Aug. 20, 1998 Sec. 102(e) Date Aug. 20, 1998 PCT Filed Jan. 15, 1997 PCT Pub. No. WO97/29142 PCT Pub. Date Aug. 14, 1997The invention relates to coating compositions for the production of coatings which are resistant to condensed water and comprise binders based on a polyurethane resin PUR which comprises alpha, omega-polymethacrylatediols (A) as structural units. The alpha, omega-polymethacrylatediols (A) preferably consist of the monomer units methyl methacrylate, ethyl methacrylate, propyl methacrylate, n-butyl methacrylate, isobutyl methacrylate, tert-butyl methacrylate, n-pentyl methacrylate, amyl methacrylate, n-hexyl methacrylate, n-octyl methacrylate, 2-ethylhexyl methacrylate, n-decyl methacrylate, cyclopentyl methacrylate, cyclohexyl methacrylate, 4-tert-butylcyclohexyl methacrylate, cyclooctyl methacrylate, phenyl methacrylate or isobornyl methacrylate or mixtures thereof. The present invention additionally relates to processes for the preparation of such coating compositions and to their preferred use as fillers, basecoats and/or topcoats, especially in connection with automotive production-line finishing and/or refinishing.
Patent AT-E252696-T1 (AT)
Inventor: ADAMS DANIEL T
IPC: F16D41/06
Filed: 1997-01-23
Granted: 2003-11-15
Abstract: A force transfer device 30 includes an inner race 40 and an outer race 38 and a plurality of reversible wedging elements 34 located between the inner and outer races. This device 30 allows for continuous force transfer between the inner and outer race. This device 30 further allows for locking the inner race 40 relative to the outer race 38 in infinitely varying positions. The device 30 includes scallops on at least one race which scallops are of complex shape in order to manage wedging of the wedging elements and surface stresses between the wedging elements and the race contact surfaces. The device 30 is also reversible.
Patent AT-E250048-T1 (AT)
Inventor: SHI YIAN
IPC: C07D493/20
Filed: 1997-10-08
Granted: 2003-10-15
Abstract: A compound and method for producing an enantiomerically enriched epoxide from an olefin using a chiral ketone and an oxidizing agent is disclosed.
Patent AT-E247951-T1 (AT)
Inventor: VENTOURAS KIMON
IPC: A61K31/00
Filed: 1997-05-06
Granted: 2003-09-15
Abstract: Slowly erodible lozenge comprises: (a) 50-99 wt.% soluble filler; (b) an insoluble film-forming agent capable of forming an insoluble matrix; (c) a swellable polymer; (d) optionally an active substance and (e) optionally conventional auxiliaries. (a) preferably comprises maltitol, xylitol, sorbitol, mannitol, lactose, dextrose, saccharose and fructose or their mixtures, and is present in an amount of 50-95 (preferably 55-95) wt.%. (b) comprises polyacrylates, ethylcellulose, polyvinyl chloride, cellulose acetate, cellulose acetate phthalate or shellac and is present in an amount of 0.5-30 (preferably 0.5-24) wt.%. (c) comprises xanthan gum, guar gum, alginic acid and its salts, pectins, polyvinyl alcohol, polysaccharides or swellable cellulose derivatives, and is present in an amount of 0.5-30 (preferably 0.5-24) wt.%.
Patent AT-E272072-T1 (AT)
Inventor: ZANETTE DINO
IPC: C12N15/09
Filed: 1997-05-21
Granted: 2004-08-15
Abstract: A process for purifying human Interleukin-1 receptor antagonist (IL-1ra), obtained by fermenting a strain of recombinant E. coli, which comprises: a) loading the mixture to be purified, which has been buffered at a pH value lower than 6.2 and optionally diluted to reduce its ionic strength at a low value, onto a cationic exchange matrix and eluting said matrix with an aqueous buffered solution having a pH value from about 7.5 to 9.0 and a low ionic strength; and b) applying the eluate from the cationic exchange step, containing the desired IL-1ra protein, directly onto an anionic exchange matrix and eluting with an aqueous buffered solution having a pH value within the above range 7.5 to 9.0 and an increased ionic strength.
Patent AT-E198823-T1 (AT)
Inventor: BACKLUND OLA
IPC: A47G9/10
Filed: 1997-07-11
Granted: 2001-02-15
Abstract: PCT No. PCT/SE97/01266 Sec. 371 Date Mar. 2, 1999 Sec. 102(e) Date Mar. 2, 1999 PCT Filed Jul. 11, 1997 PCT Pub. No. WO98/02071 PCT Pub. Date Jan. 22, 1998A pillow is provided made of resilient material and including a top side and bottom side which delimit a head section for supporting a user's head. The pillow has at least one elongated neck section adjoined to the head section wherein the upper side of the neck section is higher than the head section. The pillow is also provided with a resilient material having a channel.
Patent AT-E222180-T1 (AT)
Inventor: THOMAS JONATHAN P
IPC: B60S5/00
Filed: 1997-09-16
Granted: 2002-08-15
Abstract: A windshield repair apparatus (20) comprises a fixture (22) including a front end (48), opposed sides (44, 46) extending from the front end (48), a top surface (42) extending from the opposed sides (44, 46), and an opposite facing bottom surface (59) extending from the opposed sides (44, 46); the front end (48) defines and injector holder; and a plurality of support legs (34) extend from the bottom surface (59); the opposed sides (44, 46) define vertical engagement surfaces (36, 38) sized to be engaged by a user's thumb and fingers, respectively, and the rear (66) of the fixture (22) has a downwardly tapered top surface (42) sized to be engaged by a user's palm. <IMAGE>
Patent AT-E199712-T1 (AT)
Inventor: FRENKEL PETER
IPC: C07C407/00
Filed: 1998-01-09
Granted: 2001-03-15
Abstract: Peroxydicarbonate compounds are stabilized against decomposition by the presence of an effective amount of one or more oximes of the general formula <CHEM> wherein R<A> and R<B> are optionally substituted alkyl or alkenyl of up to 22 carbon atoms or phenyl, or form a C4-C8 cycloalkyl ring, or R<3> is oxime.
Patent AT-E198171-T1 (AT)
Inventor: SCHULZE BERND DR-ING
IPC: B23P19/04
Filed: 1998-03-25
Granted: 2001-01-15
Abstract: The punch-shaped portion (22) of the component (14) is thrust through the wall (2) by a force (Fs) opposed to one (Fd) acting against the wall rear surface. After passing through the wall, the component is held by the latter. The components can be inserted at the same time as internal shaping pressure acts against the wall, or immediately afterwards, and insertion can be under high pressure, or by shooting the component into position. A bead can be formed by the insertion operation, this then bearing against the punch portion under the internal pressure.
Patent AT-E205447-T1 (AT)
Inventor: MUELLER ROLAND DIPL ING
IPC: B60N3/10
Filed: 1998-04-08
Granted: 2001-09-15
Abstract: The holder device is made up of a housing (1) with a lowerable holder section (2) with receiver openings (3,4) for the to-be-held containers. The housing comprises a base (12), a back wall (15) and two side walls (13,14). In the centre of the back wall, parallel to the side walls, is a bendable rod-shaped guide element (16). The length of the guide element is (5) to (10%) shorter than the housing depth (a), and a stop collar (18) is located on its free end. A casing (17) is located in the centre of the holder section that is lowerably arranged between the neighbouring receiver openings for the containers. The casing has a stop collar (19) on its exposed marked end. Both the guide element and the casing may have a circular cross section.
Patent AT-E213399-T1 (AT)
Inventor: SCHMOTZER HANS DR
IPC: A61B17/58
Filed: 1998-11-20
Granted: 2002-03-15
Abstract: The shaft (4) has a proximal centring or sealing element (1), which fits on the shaft and slides on it to ensure a defined position between the centring or sealing element and the shaft. The shaft either has at least one marking or it is coupled to a positioning instrument (3). The centring or sealing element has an abutment part (2b,2c) that co-operates with the positioning instrument, to form an abutment against the centring or sealing element.
Patent AT-E422724-T1 (AT)
Inventor: MUNK-NIELSEN STIG
IPC: H02M7/523
Filed: 1998-05-19
Granted: 2009-02-15
Abstract: The invention related to a resonance inverter comprising a resonance circuit with at least one inductance and one capacitors, a switch circuit electrically connected to the resonance circuit comprising at least one power electronic component, as well as a control circuit for controlling each power electronic component in accordance with a given control algorithm or strategy, the control circuit being electrically connected to the switch circuit. The unique feature of the invention is that the resonance inverter additionally comprise a pulse generating circuit (12'; 15; 32', 31) having at least one control inductance (12', 32') which is inductively coupled to at least one of the inductances (12; 32) of the resonance circuit, whereby energy is transferred inductively to the resonance circuit.
Patent AT-E236149-T1 (AT)
Inventor: DOLL RONALD J
IPC: A61K31/4545
Filed: 1998-06-15
Granted: 2003-04-15
Abstract: Novel aminooxyamide tricyclic compounds and pharmaceutical compositions are disclosed which are inhibitors of the enzyme, farnesyl protein transferase. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering the novel aminooxyamide tricyclic compound to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human.
Patent AT-E252892-T1 (AT)
Inventor: SKINHOJ ANNETTE
IPC: A61K9/00
Filed: 1998-09-10
Granted: 2003-11-15
Abstract: An oral pharmaceutical modified release multiple-units composition for the administration of a therapeutically and/or prophylactically effective amount of a non-steroid anti-inflammatory drug substance to obtain both a relatively fast onset of the therapeutic effect and the maintenance of a therapeutically active plasma concentration for a relatively long period of time is disclosed.